Transaction

Clearwater advises the shareholders of Groupe Clinique Alpes-Belledonne on its sale to C2S

Transaction

Groupe Clinique Alpes-Belledonne sold to C2S

Sell-side

Undisclosed

Role

Adviser to the shareholders of Groupe Clinique Alpes-Belledonne on its sale to C2S

Sector

Healthcare

Region

France & Belgium

Clearwater has advised the shareholders of Groupe Clinique Alpes-Belledonne on its sale to C2S, an investment of Eurazeo Patrimoine.

Founded in 1967, the Clinique Alpes-Belledonne is a MSO (Medicine, Surgery, Obstetric) facility located in Saint-Martin-d'Hères in the East of Grenoble, resulting from the merger of Clinique des Alpes and Clinique Belledonne in September 2016. The clinic regularly ranks among the best MSO establishments in France.

The establishment has a capacity of 290 beds and relies on more than 150 practitioners. In 2018, the clinic achieved a total turnover of c. €50m with more than 35,000 stays.

With this transaction, the C2S Group continues its growth activity in the Rhône-Alpes region and will allow the Clinique Alpes-Belledonne to continue its development in the Grenoble region.

image 120

I would like to thank the Clearwater team who supported me in this sale to the C2S group. Their ability to look for investors and their support during the negotiations allowed me to quickly select the best proposal that preserved the values of the Clinique Alpes-Belledonne while ensuring its development over the coming years.

Gérard Baron, Chairman and CEO, Groupe Clinique Alpes-Belledonne
image 120

We are very proud to have contributed to the sale of Groupe Clinique Alpes-Belledonne to C2S. This clinic, located in Grenoble, is now one of the flagships of the C2S Group that we had backed by Eurazeo Patrimoine in 2018.

Clearwater

Transactions